Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 58

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

CP-31398 Restores DNA-binding Activity to Mutant p53 in Vitro but Does Not Affect p53 Homologs p63 and p73

Demma, Mark J., Wong, Serena, Maxwell, Eugene, Dasmahapatra, Bimalendu · 2004 · Journal of Biological Chemistry

Abstract

The p53 protein plays a major role in the maintenance of genome stability in mammalian cells. Mutations of p53 occur in over 50% of all cancers and are indicative of highly aggressive cancers that are hard to treat. Recently, there has been a high degree of interest in therapeutic approaches to restore growth suppression functions to mutant p53. Several compounds have been reported to restore wild type function to mutant p53. One such compound, CP-31398, has been shown effective in vivo, but questions have arisen to whether it actually affects p53. Here we show that mutant p53, isolated from cells treated with CP-31398, is capable of binding to p53 response elements in vitro. We also show the compound restores DNA-binding activity to mutant p53 in cells as determined by a chromatin immunoprecipitation assay. In addition, using purified p53 core domain from two different hotspot mutants (R273H and R249S), we show that CP-31398 can restore DNA-binding activity in a dose-dependent manner. Using a quantitative DNA binding assay, we also show that CP-31398 increases significantly the amount of mutant p53 that binds to cognate DNA (B(max)) and its affinity (K(d)) for DNA. The compound, however, does not affect the affinity (K(d) value) of wild type p53 for DNA and only increases B(max) slightly. In a similar assay PRIMA1 does not have any effect on p53 core DNA-binding activity. We also show that CP-31398 had no effect on the DNA-binding activity of p53 homologs p63 and p73.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m401854200

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 34

  1. Bernard, 2003, Human Mutat., 2, 182, 10.1002/humu.10172 · DOI · Paper page
  2. Lane, 2003, Drug Discov. Today, 8, 347, 10.1016/S1359-6446(03)02669-2 · DOI
  3. Vousden, 2000, Cell, 103, 691, 10.1016/S0092-8674(00)00171-9 · DOI · Paper page
  4. Willis, 2002, Curr. Mol. Med., 2, 329, 10.2174/1566524023362474 · DOI
  5. Bullock, 2001, Nat. Rev. Cancer, 1, 68, 10.1038/35094077 · DOI · Paper page
  6. Wong, 1999, Proc. Nat. Acad. Sci U. S. A., 96, 8348, 10.1073/pnas.96.15.8348 · DOI
  7. Bullock, 1997, Proc. Nat. Acad. Sci. U. S. A., 94, 14338, 10.1073/pnas.94.26.14338 · DOI · Paper page
  8. Bullock, 2000, Oncogene, 19, 1245, 10.1038/sj.onc.1203434 · DOI · Paper page
  9. Nicholls, 2002, J. Biol. Chem., 277, 12937, 10.1074/jbc.M108815200 · DOI
  10. Mihara, 2003, Mol. Cell, 11, 577, 10.1016/S1097-2765(03)00050-9 · DOI · Paper page
  11. Abarzua, 1996, Oncogene, 13, 2477
  12. Abarzua, 1995, Cancer Res., 55, 3490
  13. Halazonetis, 1993, EMBO J., 12, 1021, 10.1002/j.1460-2075.1993.tb05743.x · DOI · Paper page
  14. Wieczorek, 1996, Nat. Med., 2, 1143, 10.1038/nm1096-1143 · DOI
  15. Selinova, 1999, Mol. Cell Biol., 19, 3395, 10.1128/MCB.19.5.3395 · DOI · Paper page
  16. Peng, 2003, Oncogene, 22, 4478, 10.1038/sj.onc.1206777 · DOI
  17. Foster, 1999, Science, 286, 2507, 10.1126/science.286.5449.2507 · DOI · Paper page
  18. Friedler, 2002, Proc. Nat. Acad. Sci. U. S. A., 99, 937, 10.1073/pnas.241629998 · DOI · Paper page
  19. Freidler, 2003, J. Biol. Chem., 278, 24108, 10.1074/jbc.M302458200 · DOI · Paper page
  20. Issaeva, 2003, Proc. Nat. Acad. Sci. U. S. A., 100, 13303, 10.1073/pnas.1835733100 · DOI · Paper page
  21. Luu, 2002, Exp. Cell Res., 276, 214, 10.1006/excr.2002.5526 · DOI
  22. Wang, 2003, Mol. Cell Biol., 23, 2171, 10.1128/MCB.23.6.2171-2181.2003 · DOI · Paper page
  23. Takimoto, 2002, Cancer Biol. Ther., 1, 47, 10.4161/cbt.1.1.41 · DOI
  24. Rippin, 2002, Oncogene, 21, 2119, 10.1038/sj.onc.1205362 · DOI · Paper page
  25. Frank, 2001, Genes Dev., 15, 2069, 10.1101/gad.906601 · DOI · Paper page
  26. Dignam, 1983, Nucleic Acids Res., 11, 1474, 10.1093/nar/11.5.1475 · DOI · Paper page
  27. Klein, 2001, J. Biol. Chem., 276, 37390, 10.1074/jbc.M103801200 · DOI
  28. Kaeser, 2002, Proc. Nat. Acad. Sci. U. S. A., 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
  29. Friedler, 2004, J. Mol. Biol., 336, 187, 10.1016/j.jmb.2003.12.005 · DOI · Paper page
  30. Chipuk, 2003, Cancer Cell, 4, 371, 10.1016/S1535-6108(03)00272-1 · DOI · Paper page
  31. Dumont, 2003, Nat. Genet., 33, 357, 10.1038/ng1093 · DOI · Paper page
  32. Brachmann, 1998, EMBO J., 17, 1847, 10.1093/emboj/17.7.1847 · DOI · Paper page
  33. Nikolova, 2000, EMBO J., 19, 370, 10.1093/emboj/19.3.370 · DOI · Paper page
  34. Joerger, 2004, J. Biol. Chem., 279, 1291, 10.1074/jbc.M309732200 · DOI · Paper page

Cited by

See all 58

Metadata

Authors
Demma, M. J., Wong, S., Maxwell, E., & Dasmahapatra, B.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2004-10
Volume
279
Issue
44
Pages
45887-45896
ISSN
0021-9258
Cited by
58
References
3
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.